Le Lézard
Classified in: Health
Subject: SCZ

AlzRelief - Clinically Proven, 100% Natural Relief for Alzheimer's Symptoms


ROSELAND, Va., March 10, 2020 /PRNewswire/ -- Over 6 million Americans who are living with the debilitating symptoms of Alzheimer's disease can now find relief. AlzRelief is a clinically proven, 100% natural remedy to relieve memory loss, confusion, fear and anxiety.

AlzRelief alleviates many symptoms of early and middle stage Alzheimer's. It can provide meaningful improvement in the quality of life for those with the disease. Noticeable results are evident within the first month of use.

The National Institutes of Health (NIH) reports in case studies that elderly patients with dementia had good responses to treatment with the ingredients in AlzRelief, and "offers relief to dementia patients who have become forgetful and experience mental confusion and frustration."

AlzRelief is manufactured from highly diluted extracts of plants with healing properties. These ingredients include Yellow Jasmine (Gelsemium), Christmas Rose (Helleborus Niger) and Jimson Weed (Stramonium).

AlzRelief is 100% natural and safe, with no side effects and no interactions with any medications. It is sold over the counter and does not require a prescription.

To learn more about AlzRelief, visit www.alzrelief.co.

AlzRelief is product of Peerless Labs, which also manufactures TinniStop, a natural remedy for tinnitus (www.tinnistop.com), and DriNites, a clinically proven natural remedy for bedwetting (www.drinites.com).

Wayne Josephson
Owner
Peerless Labs
(434) 227-2727
waynejosephson@gmail.com 

This release was issued through WebWire(R). For more information, visit http://www.webwire.com.

SOURCE Peerless Labs


These press releases may also interest you

at 09:43
Many Americans have changed their day-to-day habits due to the coronavirus pandemic, and some of those habits can have serious health implications. ValuePenguin's latest survey has found that 1 in 4 Americans are sleeping less, while 1 in 5 are...

at 09:30
According to the new market research report "Real-Time Location Systems Market (RTLS) for healthcare with COVID-19 Impact Analysis by Offering (Hardware, Software, Services), Technology (RFID, W-Fi, UWB, BLE, IR, Ultrasound, Others), Facility Type,...

at 09:30
Therapeutics Solution International, Inc., , announced today publication on the NIH clinical trials website1 of its newly initiated trial aiming to validate a blood-based diagnostic for predicting suicide risk.  The Campbell Scoretm, which is a...

at 09:30
United Spinal Association today announced Vincenzo (Enzo) Piscopo, an experienced professional in diversity, inclusion and social causes, has been appointed president and CEO by the organization's board of directors....

at 09:30
DiA Imaging Analysis announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the commercial use of LVivo Seamless for automatic view selection. LVivo Seamless algorithms automatically run "behind the...

at 09:30
Innocoll Holdings Limited, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced today the commercial launch of XARACOLL® (bupivacaine HCI) implant for acute postsurgical pain relief up to 24 hours in adults...



News published on 10 march 2020 at 14:06 and distributed by: